THE DOUGLAS HEATH EVES CHARITABLE TRUST
Distribution of net income to charitable organisations within the UK.
Financial health, per its FY2024 accounts
The accounts state that the charity held unrestricted cash balances of £22,534 at year-end, which exceeds the trustees' estimated target of £20,000 for meeting running costs. Per the trustees' report, the charity received £33,783 in investment income and expended £38,581, resulting in a net decrease in funds for the year.
What the accounts disclose
“The charity received £33,783 (2023: £32,980) in dividends and interest from a managed investment portfolio” — page 2
“The trustees’ aim is to hold sufficient cash balances in the income account to meet the following year’s running costs and maintain the level of March grant awards. This is estimated to be in the region of £20,000.” — page 2
“G C Rothwell, a trustee, is a director of the charity’s investment managers, Vermeer LLP. Management fees of £8,028 (2023: £7,875) were paid to Vermeer LLP in the year.” — page 7
Trustees
- GERALD CHARLES ROTHWELL
- IAN WATSON MCKENZIE
Income and spending
| Financial year end | Income | Spending |
|---|---|---|
| 31/12/2025 | £32k | £38k |
| 31/12/2024 | £34k | £39k |
| 31/12/2023 | £33k | £41k |
| 31/12/2022 | £39k | £42k |
| 31/12/2021 | £32k | £41k |
Common questions
Is THE DOUGLAS HEATH EVES CHARITABLE TRUST financially healthy?
Per its FY2024 accounts: The accounts state that the charity held unrestricted cash balances of £22,534 at year-end, which exceeds the trustees' estimated target of £20,000 for meeting running costs. Per the trustees' report, the charity received £33,783 in investment income and expended £38,581, resulting in a net decrease in funds for the year. Its FY2024 accounts were independently examined.
Who funds THE DOUGLAS HEATH EVES CHARITABLE TRUST?
Funders whose own accounts filings name THE DOUGLAS HEATH EVES CHARITABLE TRUST as a grant recipient include HAEMOCHROMATOSIS UK.
Known funders
| Funder | Year | Amount | Purpose (as stated by the funder) |
|---|---|---|---|
| HAEMOCHROMATOSIS UK | FY2022 | £1k |